Abbott Laboratories (ABT) earnings · rev $44.33B
These earnings events as JSON? API free 100/dayAbbott Laboratories (ABT) is a medical devices company listed on NYSE.
This ABT earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B.
When the next ABT 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 5.7% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full ABT research stays on the stock page; the tape stays on the quote page.
ABT earnings FAQ
What are ABT's latest revenue and net income?
Latest cached Abbott Laboratories (ABT) revenue for Dec 31, 2025 was $44.33B. Net income was $6.52B. Statements: https://lician.com/financials/abt
What is ABT's latest diluted EPS?
Latest cached Abbott Laboratories (ABT) diluted EPS for Dec 31, 2025 was $3.72.
What period does the latest ABT earnings print cover?
The latest cached Abbott Laboratories (ABT) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did ABT revenue change from the prior cached period?
Cached Abbott Laboratories (ABT) revenue was up 5.7% from $41.95B (Dec 31, 2024) to $44.33B (Dec 31, 2025). Statements: https://lician.com/financials/abt
Where are ABT earnings listed?
Cached earnings facts for Abbott Laboratories (ABT) are listed at https://lician.com/earnings/abt. Statements: https://lician.com/financials/abt
Not investment advice.